These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study. Levine DE; Karia PS; Schmults CD JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278 [TBL] [Abstract][Full Text] [Related]
9. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017. Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication. Mantovani A; Teobaldi I; Stoico V; Perrone F; Zannoni M; Cima L; Bruti M; Mingolla L; Trombetta M; Bonora E Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30083351 [TBL] [Abstract][Full Text] [Related]
12. Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event? Nelson TG; Ashton RE J Surg Oncol; 2017 Nov; 116(6):783-788. PubMed ID: 28703911 [TBL] [Abstract][Full Text] [Related]
13. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079 [TBL] [Abstract][Full Text] [Related]
14. [ASSOCIATION OF SKIN PHOTOTYPE AND UV EXPOSURE WITH EXPRESSION OF HER RECEPTORS, Ki67 AND p53 IN PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA]. Drvar DL; Lipozenčić J; Mokos ZB; Ilić I; Knežević F Acta Med Croatica; 2015; 69(5):431-8. PubMed ID: 29087088 [TBL] [Abstract][Full Text] [Related]
15. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients. Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382 [TBL] [Abstract][Full Text] [Related]
17. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report. Ashraf S; Alsharedi M Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Burton KA; Ashack KA; Khachemoune A Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death. Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236 [TBL] [Abstract][Full Text] [Related]
20. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma. Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]